Alembic Pharmaceuticals informs about press release

09 Nov 2020 Evaluate

Alembic Pharmaceuticals has informed the exchange that the Company has received US Food & Drug Administration (USFDA) Tentative Approval for Palbociclib Capsules, 75 mg, 100 mg, and 125 mg. The company has enclosed its press release regarding the above subject matter on 09 November 2020.

The above information is a part of company’s filings submitted to BSE.

Alembic Pharma Share Price

847.90 12.10 (1.45%)
31-Dec-2025 14:39 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1719.70
Dr. Reddys Lab 1270.05
Cipla 1508.00
Zydus Lifesciences 912.90
Lupin 2110.25
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×